Cas:7170-22-1 quinoline-2,4-dicarbonitrile manufacturer & supplier

Chemical Name:quinoline-2,4-dicarbonitrile

CAS.NO:7170-22-1

Synonyms:2,4-DICYANOQUINOLINE;Chinolin-2,4-dicarbonsaeure;2,4,6-TRICB UNLABELED;2,4-Quinolinedicarbonitrile;2,4-Dicyan-chinolin;2,4-Chinolindicarbonitril

Molecular Formula:C₁₁H₅N₃

Molecular Weight:179.17700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:292.8ºC at 760 mmHg

Density:1.3g/cm3

Index of Refraction:1.67

PSA:60.47000

Exact Mass:179.04800

LogP:1.97816

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,4-DICYANOQUINOLINE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4-Chinolindicarbonitril physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4-Quinolinedicarbonitrile Use and application,Chinolin-2,4-dicarbonsaeure technical grade,usp/ep/jp grade.

Related News: The researchers also found that Black women are much less likely to undergo genetic counseling and testing, largely due to differences in physician recommendations or access to care. quinoline-2,4-dicarbonitrile manufacturer The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients. quinoline-2,4-dicarbonitrile supplier Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China. quinoline-2,4-dicarbonitrile vendor Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries. quinoline-2,4-dicarbonitrile factory Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China.